Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Neurological updates: neurological complications of CAR-T therapy
by
Parry-Jones, Jack
, Tallantyre, Emma C
, Morgan, Matt P
, Ingram, Wendy
, Jones, Ceri H
, Evans, Nia A
in
CD19 antigen
/ Cell therapy
/ Chimeric antigen receptors
/ Lymphocytes T
/ Neurological complications
/ Neurology
/ Neurotoxicity
/ Tumors
2021
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Neurological updates: neurological complications of CAR-T therapy
by
Parry-Jones, Jack
, Tallantyre, Emma C
, Morgan, Matt P
, Ingram, Wendy
, Jones, Ceri H
, Evans, Nia A
in
CD19 antigen
/ Cell therapy
/ Chimeric antigen receptors
/ Lymphocytes T
/ Neurological complications
/ Neurology
/ Neurotoxicity
/ Tumors
2021
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Neurological updates: neurological complications of CAR-T therapy
by
Parry-Jones, Jack
, Tallantyre, Emma C
, Morgan, Matt P
, Ingram, Wendy
, Jones, Ceri H
, Evans, Nia A
in
CD19 antigen
/ Cell therapy
/ Chimeric antigen receptors
/ Lymphocytes T
/ Neurological complications
/ Neurology
/ Neurotoxicity
/ Tumors
2021
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Neurological updates: neurological complications of CAR-T therapy
Journal Article
Neurological updates: neurological complications of CAR-T therapy
2021
Request Book From Autostore
and Choose the Collection Method
Overview
Chimeric antigen receptor (CAR)-expressing T cells now offer an effective treatment option for people with previously refractory B cell malignancies and are under development for a wide range of other tumours. However, neurological toxicity is a common complication of CAR-T cell therapy, seen in over 50% of recipients in some cohorts. Since 2018, the term immune effector cell-associated neurotoxicity syndrome (ICANS) has been used to describe and grade neurotoxicity seen after CAR-T cells and other similar therapies. ICANS following CAR-T therapy is usually self-limiting but can necessitate admission to the intensive care unit and is rarely fatal. As CAR-T therapies enter routine clinical practice, it is important for neurologists to be aware of the nature of neurological complications. Here, we summarise the clinical manifestations, mechanisms, investigations and recommended treatment of CAR-T-related neurotoxicity, focusing on the licensed CD19 products.
Publisher
Springer Nature B.V
MBRLCatalogueRelatedBooks
Related Items
Related Items
This website uses cookies to ensure you get the best experience on our website.